Cargando…
Multiparametric Magnetic Resonance Imaging Grades the Aggressiveness of Prostate Cancer
SIMPLE SUMMARY: Prostate cancer (PCa) aggressiveness can be assessed from clinical and pathologic surrogate endpoints as the International Society of Uropathology grade group (GG) in prostate biopsies, the type of pathology from surgical specimens, the clinical stage, and the risk of biochemical rec...
Autores principales: | Morote, Juan, Borque-Fernando, Angel, Triquell, Marina, Celma, Anna, Regis, Lucas, Mast, Richard, de Torres, Inés M., Semidey, María E., Santamaría, Anna, Planas, Jacques, Esteban, Luis M., Trilla, Enrique |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8997549/ https://www.ncbi.nlm.nih.gov/pubmed/35406600 http://dx.doi.org/10.3390/cancers14071828 |
Ejemplares similares
-
Improving the Early Detection of Clinically Significant Prostate Cancer in Men in the Challenging Prostate Imaging-Reporting and Data System 3 Category
por: Morote, Juan, et al.
Publicado: (2022) -
Comparison of Proclarix, PSA Density and MRI-ERSPC Risk Calculator to Select Patients for Prostate Biopsy after mpMRI
por: Campistol, Miriam, et al.
Publicado: (2022) -
Comparative Analysis of PSA Density and an MRI-Based Predictive Model to Improve the Selection of Candidates for Prostate Biopsy
por: Morote, Juan, et al.
Publicado: (2022) -
The Efficacy of Proclarix to Select Appropriate Candidates for Magnetic Resonance Imaging and Derived Prostate Biopsies in Men with Suspected Prostate Cancer
por: Morote, Juan, et al.
Publicado: (2022) -
The Barcelona Predictive Model of Clinically Significant Prostate Cancer
por: Morote, Juan, et al.
Publicado: (2022)